

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | vocalization behavior (GO:0071625) | 5.81230252 |
| 2 | locomotory exploration behavior (GO:0035641) | 5.76771788 |
| 3 | * regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.50660233 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.34997341 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.29939319 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.26458560 |
| 7 | neuron cell-cell adhesion (GO:0007158) | 5.24215586 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.17176916 |
| 9 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.05251305 |
| 10 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.01041169 |
| 11 | gamma-aminobutyric acid transport (GO:0015812) | 4.94491331 |
| 12 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.80466614 |
| 13 | neurotransmitter secretion (GO:0007269) | 4.72034888 |
| 14 | exploration behavior (GO:0035640) | 4.71895614 |
| 15 | glutamate secretion (GO:0014047) | 4.71368654 |
| 16 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.71322985 |
| 17 | behavioral response to nicotine (GO:0035095) | 4.69049337 |
| 18 | kynurenine metabolic process (GO:0070189) | 4.65797566 |
| 19 | protein localization to synapse (GO:0035418) | 4.65176371 |
| 20 | indole-containing compound catabolic process (GO:0042436) | 4.59325098 |
| 21 | indolalkylamine catabolic process (GO:0046218) | 4.59325098 |
| 22 | tryptophan catabolic process (GO:0006569) | 4.59325098 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.53389233 |
| 24 | regulation of gene silencing by RNA (GO:0060966) | 4.45605216 |
| 25 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.45605216 |
| 26 | regulation of gene silencing by miRNA (GO:0060964) | 4.45605216 |
| 27 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.45589817 |
| 28 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.40233880 |
| 29 | indolalkylamine metabolic process (GO:0006586) | 4.32991071 |
| 30 | glutamate receptor signaling pathway (GO:0007215) | 4.30555774 |
| 31 | regulation of synapse structural plasticity (GO:0051823) | 4.26928933 |
| 32 | neuronal action potential propagation (GO:0019227) | 4.19585626 |
| 33 | neuron-neuron synaptic transmission (GO:0007270) | 4.14680009 |
| 34 | synaptic transmission, glutamatergic (GO:0035249) | 4.11572079 |
| 35 | * regulation of neuronal synaptic plasticity (GO:0048168) | 4.09170115 |
| 36 | layer formation in cerebral cortex (GO:0021819) | 4.05226834 |
| 37 | serotonin metabolic process (GO:0042428) | 4.01917038 |
| 38 | proline transport (GO:0015824) | 3.99842468 |
| 39 | regulation of synaptic vesicle transport (GO:1902803) | 3.97932331 |
| 40 | long-term memory (GO:0007616) | 3.95454950 |
| 41 | cellular potassium ion homeostasis (GO:0030007) | 3.95428685 |
| 42 | tryptophan metabolic process (GO:0006568) | 3.92655599 |
| 43 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.89944960 |
| 44 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.89944960 |
| 45 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.89944960 |
| 46 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.89866676 |
| 47 | signal peptide processing (GO:0006465) | 3.88426615 |
| 48 | neurotransmitter transport (GO:0006836) | 3.87493870 |
| 49 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.82008446 |
| 50 | transmission of nerve impulse (GO:0019226) | 3.80188455 |
| 51 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.79938665 |
| 52 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.79853976 |
| 53 | response to histamine (GO:0034776) | 3.77541814 |
| 54 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.77462162 |
| 55 | indole-containing compound metabolic process (GO:0042430) | 3.76426812 |
| 56 | regulation of hippo signaling (GO:0035330) | 3.76417360 |
| 57 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.75442804 |
| 58 | positive regulation of synapse maturation (GO:0090129) | 3.73012102 |
| 59 | neuron recognition (GO:0008038) | 3.70284251 |
| 60 | regulation of neurotransmitter levels (GO:0001505) | 3.69591345 |
| 61 | primary amino compound metabolic process (GO:1901160) | 3.68069760 |
| 62 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.66945926 |
| 63 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.66640996 |
| 64 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.65794972 |
| 65 | sodium ion export (GO:0071436) | 3.64746651 |
| 66 | regulation of postsynaptic membrane potential (GO:0060078) | 3.60855368 |
| 67 | fucose catabolic process (GO:0019317) | 3.60652865 |
| 68 | L-fucose metabolic process (GO:0042354) | 3.60652865 |
| 69 | L-fucose catabolic process (GO:0042355) | 3.60652865 |
| 70 | dendritic spine morphogenesis (GO:0060997) | 3.59482088 |
| 71 | positive regulation of membrane potential (GO:0045838) | 3.59005521 |
| 72 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.58723495 |
| 73 | postsynaptic membrane organization (GO:0001941) | 3.54448546 |
| 74 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.51795721 |
| 75 | neuronal action potential (GO:0019228) | 3.49266282 |
| 76 | sulfation (GO:0051923) | 3.47958826 |
| 77 | prepulse inhibition (GO:0060134) | 3.47051213 |
| 78 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.46655177 |
| 79 | long-term synaptic potentiation (GO:0060291) | 3.43979555 |
| 80 | regulation of pigment cell differentiation (GO:0050932) | 3.43592454 |
| 81 | reflex (GO:0060004) | 3.42871168 |
| 82 | startle response (GO:0001964) | 3.40760010 |
| 83 | presynaptic membrane assembly (GO:0097105) | 3.38939592 |
| 84 | positive regulation of developmental pigmentation (GO:0048087) | 3.37599294 |
| 85 | * regulation of synaptic plasticity (GO:0048167) | 3.35863287 |
| 86 | detection of light stimulus involved in visual perception (GO:0050908) | 3.35483890 |
| 87 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.35483890 |
| 88 | auditory behavior (GO:0031223) | 3.34862687 |
| 89 | membrane depolarization during action potential (GO:0086010) | 3.34777026 |
| 90 | regulation of vesicle fusion (GO:0031338) | 3.32466081 |
| 91 | synapse assembly (GO:0007416) | 3.31648566 |
| 92 | response to auditory stimulus (GO:0010996) | 3.28252027 |
| 93 | regulation of sarcomere organization (GO:0060297) | 3.28129274 |
| 94 | cell communication by electrical coupling (GO:0010644) | 3.26795362 |
| 95 | axonal fasciculation (GO:0007413) | 3.25197763 |
| 96 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.24684037 |
| 97 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.24215337 |
| 98 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.23954656 |
| 99 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.23792293 |
| 100 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.22982939 |
| 101 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.22580486 |
| 102 | learning (GO:0007612) | 3.19974665 |
| 103 | protein K48-linked deubiquitination (GO:0071108) | 3.19331309 |
| 104 | behavioral fear response (GO:0001662) | 3.18285544 |
| 105 | behavioral defense response (GO:0002209) | 3.18285544 |
| 106 | negative regulation of sodium ion transport (GO:0010766) | 3.17783698 |
| 107 | behavioral response to ethanol (GO:0048149) | 3.17579033 |
| 108 | regulation of neurotransmitter secretion (GO:0046928) | 3.15215935 |
| 109 | striatum development (GO:0021756) | 3.14855016 |
| 110 | regulation of establishment of cell polarity (GO:2000114) | 3.14123657 |
| 111 | activation of protein kinase A activity (GO:0034199) | 3.13877159 |
| 112 | membrane hyperpolarization (GO:0060081) | 3.12535958 |
| 113 | neural tube formation (GO:0001841) | 3.11586968 |
| 114 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.11300761 |
| 115 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.11161466 |
| 116 | NAD biosynthetic process (GO:0009435) | 3.10660285 |
| 117 | neuromuscular process controlling balance (GO:0050885) | 3.10010100 |
| 118 | fear response (GO:0042596) | 3.10009947 |
| 119 | neuronal ion channel clustering (GO:0045161) | 3.09792300 |
| 120 | flavonoid metabolic process (GO:0009812) | 3.09131502 |
| 121 | interkinetic nuclear migration (GO:0022027) | 3.08828279 |
| 122 | neuromuscular process controlling posture (GO:0050884) | 3.08161196 |
| 123 | membrane depolarization (GO:0051899) | 3.06268819 |
| 124 | oxidative demethylation (GO:0070989) | 3.06194695 |
| 125 | behavioral response to cocaine (GO:0048148) | 3.06185858 |
| 126 | cerebellar granule cell differentiation (GO:0021707) | 3.04750728 |
| 127 | snRNA transcription (GO:0009301) | 3.04650899 |
| 128 | presynaptic membrane organization (GO:0097090) | 3.04428661 |
| 129 | dendrite morphogenesis (GO:0048813) | 3.04384922 |
| 130 | regulation of synaptic transmission, GABAergic (GO:0032228) | 3.03100475 |
| 131 | mating behavior (GO:0007617) | 3.02690484 |
| 132 | regulation of neurotransmitter transport (GO:0051588) | 3.00939411 |
| 133 | social behavior (GO:0035176) | 3.00301786 |
| 134 | intraspecies interaction between organisms (GO:0051703) | 3.00301786 |
| 135 | positive regulation of synaptic transmission (GO:0050806) | 2.99665232 |
| 136 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.99431274 |
| 137 | synaptic transmission (GO:0007268) | 2.98034810 |
| 138 | regulation of synapse maturation (GO:0090128) | 2.97855974 |
| 139 | synaptic transmission, dopaminergic (GO:0001963) | 2.97749115 |
| 140 | positive regulation of neurotransmitter transport (GO:0051590) | 2.97645930 |
| 141 | synaptic vesicle endocytosis (GO:0048488) | 2.97465326 |
| 142 | regulation of glutamate secretion (GO:0014048) | 2.95836259 |
| 143 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.95533107 |
| 144 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.93870236 |
| 145 | glycine transport (GO:0015816) | 2.93715679 |
| 146 | cellular ketone body metabolic process (GO:0046950) | 2.88885708 |
| 147 | establishment of protein localization to Golgi (GO:0072600) | 2.87147087 |
| 148 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.79285195 |
| 149 | photoreceptor cell maintenance (GO:0045494) | 2.77488325 |
| 150 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.76871740 |
| 151 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.76070810 |
| 152 | negative regulation of protein localization to cell surface (GO:2000009) | 2.74804577 |
| 153 | retinal cone cell development (GO:0046549) | 2.72818918 |
| 154 | limb development (GO:0060173) | 2.72666082 |
| 155 | appendage development (GO:0048736) | 2.72666082 |
| 156 | protein K11-linked deubiquitination (GO:0035871) | 2.71849435 |
| 157 | amine catabolic process (GO:0009310) | 2.70118471 |
| 158 | cellular biogenic amine catabolic process (GO:0042402) | 2.70118471 |
| 159 | thyroid hormone metabolic process (GO:0042403) | 2.66975872 |
| 160 | spinal cord motor neuron differentiation (GO:0021522) | 2.66397597 |
| 161 | peristalsis (GO:0030432) | 2.64537262 |
| 162 | cardiovascular system development (GO:0072358) | 2.64345163 |
| 163 | lipid translocation (GO:0034204) | 2.61246059 |
| 164 | phospholipid translocation (GO:0045332) | 2.61246059 |
| 165 | protein K63-linked deubiquitination (GO:0070536) | 2.60806100 |
| 166 | endosome to pigment granule transport (GO:0043485) | 2.59799638 |
| 167 | endosome to melanosome transport (GO:0035646) | 2.59799638 |
| 168 | kidney morphogenesis (GO:0060993) | 2.58243403 |
| 169 | cellular response to sterol (GO:0036315) | 2.56963391 |
| 170 | ketone body metabolic process (GO:1902224) | 2.54641405 |
| 171 | potassium ion transmembrane transport (GO:0071805) | 2.54553164 |
| 172 | cellular potassium ion transport (GO:0071804) | 2.54553164 |
| 173 | regulation of collateral sprouting (GO:0048670) | 2.53854805 |
| 174 | cAMP catabolic process (GO:0006198) | 2.53422597 |
| 175 | benzene-containing compound metabolic process (GO:0042537) | 2.49355843 |
| 176 | central nervous system neuron axonogenesis (GO:0021955) | 2.47669853 |
| 177 | nonmotile primary cilium assembly (GO:0035058) | 2.47239913 |
| 178 | action potential (GO:0001508) | 2.47069351 |
| 179 | response to pheromone (GO:0019236) | 2.46705809 |
| 180 | axon ensheathment in central nervous system (GO:0032291) | 2.44130112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.20422541 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.67624420 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.18709864 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.14317313 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07546676 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.68068364 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.68068364 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.67871878 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.64555540 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.58903682 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.56002068 |
| 12 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.55757303 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51207107 |
| 14 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.47127958 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.46109208 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.35436671 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.32667689 |
| 18 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.32253908 |
| 19 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.25496254 |
| 20 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.23614122 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.20183820 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.18857282 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.18588276 |
| 24 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.14502406 |
| 25 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.11557034 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.08673178 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.05623947 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.01383380 |
| 29 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.94885087 |
| 30 | EWS_26573619_Chip-Seq_HEK293_Human | 1.94149998 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.92527563 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.89865713 |
| 33 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.79790886 |
| 34 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.77793786 |
| 35 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76475434 |
| 36 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.72913451 |
| 37 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.72502353 |
| 38 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70959320 |
| 39 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61512206 |
| 40 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.56265276 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54157127 |
| 42 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.53854112 |
| 43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.51792949 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48096724 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47651673 |
| 46 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.47191257 |
| 47 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.45306099 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44675368 |
| 49 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.43176043 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42587426 |
| 51 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.42296260 |
| 52 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.39576063 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.39576063 |
| 54 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.38401076 |
| 55 | AR_25329375_ChIP-Seq_VCAP_Human | 1.38296776 |
| 56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.37363206 |
| 57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37242035 |
| 58 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36668253 |
| 59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.35804555 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33058060 |
| 61 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.30283790 |
| 62 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.29144197 |
| 63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29127208 |
| 64 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28605389 |
| 65 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28526176 |
| 66 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.28393421 |
| 67 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.28057013 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27840159 |
| 69 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.27043310 |
| 70 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25988685 |
| 71 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.25132389 |
| 72 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25129762 |
| 73 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.23645941 |
| 74 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22889189 |
| 75 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.21554018 |
| 76 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.21332478 |
| 77 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.21032404 |
| 78 | FUS_26573619_Chip-Seq_HEK293_Human | 1.20176863 |
| 79 | AR_19668381_ChIP-Seq_PC3_Human | 1.18227038 |
| 80 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16609419 |
| 81 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16257284 |
| 82 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15802943 |
| 83 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15797555 |
| 84 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15076929 |
| 85 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.14381943 |
| 86 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13899787 |
| 87 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.13485507 |
| 88 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.12790995 |
| 89 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12313854 |
| 90 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11999688 |
| 91 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11410916 |
| 92 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.10790291 |
| 93 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.10790291 |
| 94 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.10482455 |
| 95 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.09916652 |
| 96 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09728284 |
| 97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.09671772 |
| 98 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09570396 |
| 99 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09021503 |
| 100 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.08421101 |
| 101 | TCF4_23295773_ChIP-Seq_U87_Human | 1.08212575 |
| 102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08025008 |
| 103 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07714358 |
| 104 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.07668863 |
| 105 | * CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.07580263 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.06904680 |
| 107 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05089283 |
| 108 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04827778 |
| 109 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04362948 |
| 110 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.04277874 |
| 111 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04257926 |
| 112 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04169916 |
| 113 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01308339 |
| 114 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00857342 |
| 115 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.00227842 |
| 116 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00196145 |
| 117 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99998272 |
| 118 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99785930 |
| 119 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99205989 |
| 120 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98625340 |
| 121 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98262940 |
| 122 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97482614 |
| 123 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96939158 |
| 124 | RXR_22108803_ChIP-Seq_LS180_Human | 0.96458613 |
| 125 | JUN_21703547_ChIP-Seq_K562_Human | 0.95204622 |
| 126 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93559438 |
| 127 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.93559438 |
| 128 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91073355 |
| 129 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88311359 |
| 130 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88134209 |
| 131 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87812718 |
| 132 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87511805 |
| 133 | VDR_22108803_ChIP-Seq_LS180_Human | 0.87511295 |
| 134 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87188478 |
| 135 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.86661278 |
| 136 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.86128833 |
| 137 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.85295530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.82705285 |
| 2 | MP0003880_abnormal_central_pattern | 4.67488553 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.14732386 |
| 4 | MP0002822_catalepsy | 4.14315824 |
| 5 | MP0009745_abnormal_behavioral_response | 3.61716211 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.31890412 |
| 7 | MP0004270_analgesia | 3.28532685 |
| 8 | MP0009046_muscle_twitch | 3.27947788 |
| 9 | MP0002064_seizures | 3.26761248 |
| 10 | MP0005423_abnormal_somatic_nervous | 3.15452899 |
| 11 | MP0003195_calcinosis | 3.14202667 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.99184430 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.80610309 |
| 14 | MP0001486_abnormal_startle_reflex | 2.63254167 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.60886624 |
| 16 | MP0003646_muscle_fatigue | 2.60152285 |
| 17 | MP0002272_abnormal_nervous_system | 2.57990417 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.46790259 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.35591441 |
| 20 | MP0004043_abnormal_pH_regulation | 2.29376307 |
| 21 | MP0008877_abnormal_DNA_methylation | 2.25246444 |
| 22 | MP0008057_abnormal_DNA_replication | 2.22219462 |
| 23 | MP0005646_abnormal_pituitary_gland | 2.12375714 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 2.10614613 |
| 25 | MP0002735_abnormal_chemical_nociception | 2.07346314 |
| 26 | MP0002736_abnormal_nociception_after | 2.06940041 |
| 27 | MP0002733_abnormal_thermal_nociception | 2.05387504 |
| 28 | MP0003329_amyloid_beta_deposits | 2.00662934 |
| 29 | MP0002067_abnormal_sensory_capabilities | 1.97109756 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.96609059 |
| 31 | MP0004924_abnormal_behavior | 1.96609059 |
| 32 | MP0006276_abnormal_autonomic_nervous | 1.93662211 |
| 33 | MP0001970_abnormal_pain_threshold | 1.93491781 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.89635451 |
| 35 | MP0004858_abnormal_nervous_system | 1.86520735 |
| 36 | MP0008569_lethality_at_weaning | 1.78131124 |
| 37 | MP0003136_yellow_coat_color | 1.77597129 |
| 38 | MP0001984_abnormal_olfaction | 1.73555985 |
| 39 | MP0000427_abnormal_hair_cycle | 1.72257224 |
| 40 | MP0002184_abnormal_innervation | 1.71194039 |
| 41 | MP0001529_abnormal_vocalization | 1.67495868 |
| 42 | MP0002909_abnormal_adrenal_gland | 1.66243055 |
| 43 | MP0000778_abnormal_nervous_system | 1.60555796 |
| 44 | MP0004885_abnormal_endolymph | 1.57019240 |
| 45 | MP0001905_abnormal_dopamine_level | 1.54235790 |
| 46 | MP0002102_abnormal_ear_morphology | 1.51402939 |
| 47 | MP0003890_abnormal_embryonic-extraembry | 1.51171295 |
| 48 | MP0004811_abnormal_neuron_physiology | 1.49670300 |
| 49 | MP0004133_heterotaxia | 1.46050818 |
| 50 | MP0006292_abnormal_olfactory_placode | 1.43654237 |
| 51 | MP0000955_abnormal_spinal_cord | 1.40588729 |
| 52 | MP0001188_hyperpigmentation | 1.40117701 |
| 53 | MP0002066_abnormal_motor_capabilities/c | 1.38130996 |
| 54 | MP0005253_abnormal_eye_physiology | 1.37232890 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.36006262 |
| 56 | MP0003879_abnormal_hair_cell | 1.35824351 |
| 57 | MP0004142_abnormal_muscle_tone | 1.35792603 |
| 58 | MP0002882_abnormal_neuron_morphology | 1.33719528 |
| 59 | MP0003633_abnormal_nervous_system | 1.24766761 |
| 60 | MP0003122_maternal_imprinting | 1.24402573 |
| 61 | MP0001502_abnormal_circadian_rhythm | 1.23572875 |
| 62 | MP0003787_abnormal_imprinting | 1.23169772 |
| 63 | MP0004147_increased_porphyrin_level | 1.21789615 |
| 64 | MP0000383_abnormal_hair_follicle | 1.21736410 |
| 65 | MP0005174_abnormal_tail_pigmentation | 1.19808816 |
| 66 | MP0002938_white_spotting | 1.17036789 |
| 67 | MP0003119_abnormal_digestive_system | 1.16105915 |
| 68 | MP0001986_abnormal_taste_sensitivity | 1.14992851 |
| 69 | MP0004130_abnormal_muscle_cell | 1.14143673 |
| 70 | MP0008872_abnormal_physiological_respon | 1.12920772 |
| 71 | MP0002653_abnormal_ependyma_morphology | 1.12721905 |
| 72 | MP0003631_nervous_system_phenotype | 1.09973077 |
| 73 | MP0003690_abnormal_glial_cell | 1.09761435 |
| 74 | MP0002152_abnormal_brain_morphology | 1.04815239 |
| 75 | MP0006072_abnormal_retinal_apoptosis | 1.03381633 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 0.99100318 |
| 77 | MP0002928_abnormal_bile_duct | 0.96918224 |
| 78 | MP0010386_abnormal_urinary_bladder | 0.96590447 |
| 79 | MP0008874_decreased_physiological_sensi | 0.95515956 |
| 80 | MP0000751_myopathy | 0.94788469 |
| 81 | MP0001177_atelectasis | 0.94505225 |
| 82 | MP0003878_abnormal_ear_physiology | 0.93845274 |
| 83 | MP0005377_hearing/vestibular/ear_phenot | 0.93845274 |
| 84 | MP0000604_amyloidosis | 0.93611796 |
| 85 | MP0005195_abnormal_posterior_eye | 0.93339214 |
| 86 | MP0004085_abnormal_heartbeat | 0.91981970 |
| 87 | MP0003937_abnormal_limbs/digits/tail_de | 0.91288737 |
| 88 | MP0002638_abnormal_pupillary_reflex | 0.90915582 |
| 89 | MP0000230_abnormal_systemic_arterial | 0.90052325 |
| 90 | MP0002069_abnormal_eating/drinking_beha | 0.89550970 |
| 91 | MP0003634_abnormal_glial_cell | 0.88441226 |
| 92 | MP0002229_neurodegeneration | 0.87683362 |
| 93 | MP0005535_abnormal_body_temperature | 0.87266741 |
| 94 | MP0005409_darkened_coat_color | 0.86812577 |
| 95 | MP0003632_abnormal_nervous_system | 0.85676835 |
| 96 | MP0004742_abnormal_vestibular_system | 0.85652877 |
| 97 | MP0004215_abnormal_myocardial_fiber | 0.84436188 |
| 98 | MP0000013_abnormal_adipose_tissue | 0.83515657 |
| 99 | MP0005266_abnormal_metabolism | 0.82676003 |
| 100 | MP0002138_abnormal_hepatobiliary_system | 0.81211097 |
| 101 | MP0002876_abnormal_thyroid_physiology | 0.80776662 |
| 102 | MP0000538_abnormal_urinary_bladder | 0.79542461 |
| 103 | MP0003698_abnormal_male_reproductive | 0.78955266 |
| 104 | MP0003075_altered_response_to | 0.78793706 |
| 105 | MP0003718_maternal_effect | 0.78661463 |
| 106 | MP0001963_abnormal_hearing_physiology | 0.78123321 |
| 107 | MP0002090_abnormal_vision | 0.77861198 |
| 108 | MP0000631_abnormal_neuroendocrine_gland | 0.77562487 |
| 109 | MP0003045_fibrosis | 0.74911217 |
| 110 | MP0005448_abnormal_energy_balance | 0.73522519 |
| 111 | MP0000372_irregular_coat_pigmentation | 0.73520755 |
| 112 | MP0005310_abnormal_salivary_gland | 0.73253850 |
| 113 | MP0002751_abnormal_autonomic_nervous | 0.72307709 |
| 114 | MP0003252_abnormal_bile_duct | 0.71874447 |
| 115 | MP0005171_absent_coat_pigmentation | 0.70326504 |
| 116 | MP0002752_abnormal_somatic_nervous | 0.70214884 |
| 117 | MP0000569_abnormal_digit_pigmentation | 0.69749145 |
| 118 | MP0004145_abnormal_muscle_electrophysio | 0.66945500 |
| 119 | MP0003137_abnormal_impulse_conducting | 0.66717192 |
| 120 | MP0000920_abnormal_myelination | 0.64286768 |
| 121 | MP0005394_taste/olfaction_phenotype | 0.63824701 |
| 122 | MP0005499_abnormal_olfactory_system | 0.63824701 |
| 123 | MP0002837_dystrophic_cardiac_calcinosis | 0.62621682 |
| 124 | MP0001299_abnormal_eye_distance/ | 0.59953156 |
| 125 | MP0001943_abnormal_respiration | 0.59519590 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.58944894 |
| 127 | MP0001664_abnormal_digestion | 0.58250940 |
| 128 | MP0005623_abnormal_meninges_morphology | 0.56768656 |
| 129 | MP0004484_altered_response_of | 0.56189359 |
| 130 | MP0004233_abnormal_muscle_weight | 0.55199239 |
| 131 | MP0001485_abnormal_pinna_reflex | 0.54364117 |
| 132 | MP0010770_preweaning_lethality | 0.50800511 |
| 133 | MP0002082_postnatal_lethality | 0.50800511 |
| 134 | MP0010769_abnormal_survival | 0.50741445 |
| 135 | MP0008961_abnormal_basal_metabolism | 0.50084439 |
| 136 | MP0000026_abnormal_inner_ear | 0.49514994 |
| 137 | MP0003861_abnormal_nervous_system | 0.47572358 |
| 138 | MP0010768_mortality/aging | 0.46972717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.38502347 |
| 2 | Myokymia (HP:0002411) | 6.14454622 |
| 3 | Focal seizures (HP:0007359) | 6.03486428 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.90995193 |
| 5 | Visual hallucinations (HP:0002367) | 4.87956119 |
| 6 | Atonic seizures (HP:0010819) | 4.86624227 |
| 7 | Pancreatic cysts (HP:0001737) | 4.62496581 |
| 8 | Febrile seizures (HP:0002373) | 4.62163273 |
| 9 | Absence seizures (HP:0002121) | 4.32505506 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 4.16313173 |
| 11 | Pancreatic fibrosis (HP:0100732) | 4.10321587 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 4.08697970 |
| 13 | Dialeptic seizures (HP:0011146) | 4.05067299 |
| 14 | Hyperventilation (HP:0002883) | 4.02594614 |
| 15 | True hermaphroditism (HP:0010459) | 3.96276977 |
| 16 | Broad-based gait (HP:0002136) | 3.54371955 |
| 17 | Abnormality of midbrain morphology (HP:0002418) | 3.44137039 |
| 18 | Molar tooth sign on MRI (HP:0002419) | 3.44137039 |
| 19 | Supranuclear gaze palsy (HP:0000605) | 3.41609331 |
| 20 | Congenital stationary night blindness (HP:0007642) | 3.39602457 |
| 21 | Diplopia (HP:0000651) | 3.37481944 |
| 22 | Abnormality of binocular vision (HP:0011514) | 3.37481944 |
| 23 | Poor eye contact (HP:0000817) | 3.37351817 |
| 24 | Action tremor (HP:0002345) | 3.36720911 |
| 25 | Progressive inability to walk (HP:0002505) | 3.30248875 |
| 26 | Impaired social interactions (HP:0000735) | 3.25021709 |
| 27 | Abnormal social behavior (HP:0012433) | 3.25021709 |
| 28 | Dysdiadochokinesis (HP:0002075) | 3.22699514 |
| 29 | Neurofibrillary tangles (HP:0002185) | 3.19121531 |
| 30 | Cystic liver disease (HP:0006706) | 3.17920523 |
| 31 | Nephronophthisis (HP:0000090) | 3.16150479 |
| 32 | Hemiparesis (HP:0001269) | 3.11413966 |
| 33 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.08574906 |
| 34 | Anxiety (HP:0000739) | 3.03363715 |
| 35 | Depression (HP:0000716) | 3.03164909 |
| 36 | Gaze-evoked nystagmus (HP:0000640) | 3.02622497 |
| 37 | Truncal ataxia (HP:0002078) | 3.02590564 |
| 38 | Ankle clonus (HP:0011448) | 3.02114623 |
| 39 | Postural instability (HP:0002172) | 3.02040381 |
| 40 | Cerebral inclusion bodies (HP:0100314) | 3.01014799 |
| 41 | Attenuation of retinal blood vessels (HP:0007843) | 3.00973906 |
| 42 | Abnormal eating behavior (HP:0100738) | 2.95683713 |
| 43 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.89891643 |
| 44 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.88269093 |
| 45 | Limb dystonia (HP:0002451) | 2.87109148 |
| 46 | Abnormality of the renal medulla (HP:0100957) | 2.85673295 |
| 47 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.85565181 |
| 48 | Abnormality of alanine metabolism (HP:0010916) | 2.85565181 |
| 49 | Hyperalaninemia (HP:0003348) | 2.85565181 |
| 50 | Dysmetria (HP:0001310) | 2.83774970 |
| 51 | Medial flaring of the eyebrow (HP:0010747) | 2.83109866 |
| 52 | Mutism (HP:0002300) | 2.80665124 |
| 53 | Hemiplegia (HP:0002301) | 2.79477420 |
| 54 | Abnormality of the renal cortex (HP:0011035) | 2.78337724 |
| 55 | Abolished electroretinogram (ERG) (HP:0000550) | 2.75869561 |
| 56 | Amblyopia (HP:0000646) | 2.74907203 |
| 57 | Excessive salivation (HP:0003781) | 2.72812305 |
| 58 | Drooling (HP:0002307) | 2.72812305 |
| 59 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.71900876 |
| 60 | Papilledema (HP:0001085) | 2.69684951 |
| 61 | Aplasia involving bones of the extremities (HP:0009825) | 2.68765445 |
| 62 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.68765445 |
| 63 | Aplasia of the phalanges of the hand (HP:0009802) | 2.68765445 |
| 64 | Genetic anticipation (HP:0003743) | 2.66504690 |
| 65 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.66337483 |
| 66 | Absent speech (HP:0001344) | 2.65788481 |
| 67 | Fair hair (HP:0002286) | 2.65512982 |
| 68 | Chronic hepatic failure (HP:0100626) | 2.64266001 |
| 69 | Furrowed tongue (HP:0000221) | 2.53308348 |
| 70 | Polyphagia (HP:0002591) | 2.50297536 |
| 71 | Status epilepticus (HP:0002133) | 2.49100927 |
| 72 | Sclerocornea (HP:0000647) | 2.48975391 |
| 73 | Bradykinesia (HP:0002067) | 2.48524040 |
| 74 | Tubular atrophy (HP:0000092) | 2.45546012 |
| 75 | Inability to walk (HP:0002540) | 2.45270423 |
| 76 | Epileptiform EEG discharges (HP:0011182) | 2.42658003 |
| 77 | Type II lissencephaly (HP:0007260) | 2.42093968 |
| 78 | Torticollis (HP:0000473) | 2.41670836 |
| 79 | Hypoplastic ischia (HP:0003175) | 2.38867233 |
| 80 | Stereotypic behavior (HP:0000733) | 2.36666540 |
| 81 | Blue irides (HP:0000635) | 2.36181560 |
| 82 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.35258255 |
| 83 | Scanning speech (HP:0002168) | 2.34969247 |
| 84 | EEG with generalized epileptiform discharges (HP:0011198) | 2.33772499 |
| 85 | Patellar aplasia (HP:0006443) | 2.32110322 |
| 86 | Genital tract atresia (HP:0001827) | 2.30801065 |
| 87 | Congenital primary aphakia (HP:0007707) | 2.30052411 |
| 88 | Megalencephaly (HP:0001355) | 2.27304555 |
| 89 | Vaginal atresia (HP:0000148) | 2.27033017 |
| 90 | Impaired smooth pursuit (HP:0007772) | 2.26197378 |
| 91 | Large for gestational age (HP:0001520) | 2.25298806 |
| 92 | Hypsarrhythmia (HP:0002521) | 2.24734898 |
| 93 | Birth length less than 3rd percentile (HP:0003561) | 2.24389165 |
| 94 | Spastic gait (HP:0002064) | 2.20535425 |
| 95 | Focal dystonia (HP:0004373) | 2.20383369 |
| 96 | Anencephaly (HP:0002323) | 2.18859446 |
| 97 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.17494583 |
| 98 | Generalized myoclonic seizures (HP:0002123) | 2.16854141 |
| 99 | Urinary urgency (HP:0000012) | 2.16557236 |
| 100 | Abnormality of the ischium (HP:0003174) | 2.16539264 |
| 101 | Pendular nystagmus (HP:0012043) | 2.15166898 |
| 102 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.13414079 |
| 103 | Lissencephaly (HP:0001339) | 2.12895035 |
| 104 | Preaxial foot polydactyly (HP:0001841) | 2.11951900 |
| 105 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.11681205 |
| 106 | Congenital sensorineural hearing impairment (HP:0008527) | 2.10601466 |
| 107 | Polydipsia (HP:0001959) | 2.10316286 |
| 108 | Abnormal drinking behavior (HP:0030082) | 2.10316286 |
| 109 | Keratoconus (HP:0000563) | 2.09970506 |
| 110 | Increased corneal curvature (HP:0100692) | 2.09970506 |
| 111 | Decreased circulating renin level (HP:0003351) | 2.09781357 |
| 112 | Congenital hepatic fibrosis (HP:0002612) | 2.08941122 |
| 113 | Fetal akinesia sequence (HP:0001989) | 2.08697812 |
| 114 | Pheochromocytoma (HP:0002666) | 2.08425778 |
| 115 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.08409917 |
| 116 | Absent/shortened dynein arms (HP:0200106) | 2.08409917 |
| 117 | Nephrogenic diabetes insipidus (HP:0009806) | 2.08173905 |
| 118 | Intention tremor (HP:0002080) | 2.07702225 |
| 119 | Gait imbalance (HP:0002141) | 2.07252467 |
| 120 | Lower limb muscle weakness (HP:0007340) | 2.06346424 |
| 121 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.05910432 |
| 122 | Stomach cancer (HP:0012126) | 2.05798915 |
| 123 | Generalized hypopigmentation of hair (HP:0011358) | 2.05438120 |
| 124 | Congenital, generalized hypertrichosis (HP:0004540) | 2.03502915 |
| 125 | Agitation (HP:0000713) | 2.00961599 |
| 126 | Abnormality of the corticospinal tract (HP:0002492) | 2.00716461 |
| 127 | Cerebellar dysplasia (HP:0007033) | 2.00236354 |
| 128 | Chorioretinal atrophy (HP:0000533) | 1.97725797 |
| 129 | Craniofacial dystonia (HP:0012179) | 1.97550238 |
| 130 | Widely spaced teeth (HP:0000687) | 1.97016577 |
| 131 | Hypoplasia of the pons (HP:0012110) | 1.96792712 |
| 132 | Hypoventilation (HP:0002791) | 1.96215991 |
| 133 | Dysmetric saccades (HP:0000641) | 1.94719655 |
| 134 | Decreased central vision (HP:0007663) | 1.94299515 |
| 135 | Poor coordination (HP:0002370) | 1.94081048 |
| 136 | Small hand (HP:0200055) | 1.91841397 |
| 137 | Gait ataxia (HP:0002066) | 1.91788854 |
| 138 | Hyperthyroidism (HP:0000836) | 1.91681283 |
| 139 | Optic nerve hypoplasia (HP:0000609) | 1.91659038 |
| 140 | Abnormality of the pons (HP:0007361) | 1.91144883 |
| 141 | Rigidity (HP:0002063) | 1.90723880 |
| 142 | Clumsiness (HP:0002312) | 1.90381113 |
| 143 | Impaired vibratory sensation (HP:0002495) | 1.88790840 |
| 144 | Protruding tongue (HP:0010808) | 1.88517080 |
| 145 | Psychosis (HP:0000709) | 1.88192652 |
| 146 | Neuroendocrine neoplasm (HP:0100634) | 1.87931443 |
| 147 | Specific learning disability (HP:0001328) | 1.87748423 |
| 148 | Abnormality of salivation (HP:0100755) | 1.87540078 |
| 149 | Abnormality of the pubic bones (HP:0003172) | 1.86299514 |
| 150 | Increased cerebral lipofuscin (HP:0011813) | 1.85178995 |
| 151 | Insidious onset (HP:0003587) | 1.83576608 |
| 152 | Termporal pattern (HP:0011008) | 1.83576608 |
| 153 | Neuronal loss in central nervous system (HP:0002529) | 1.81818691 |
| 154 | Inappropriate behavior (HP:0000719) | 1.81384935 |
| 155 | Male pseudohermaphroditism (HP:0000037) | 1.80879798 |
| 156 | Short foot (HP:0001773) | 1.80643681 |
| 157 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.80635702 |
| 158 | Preaxial hand polydactyly (HP:0001177) | 1.79625557 |
| 159 | Resting tremor (HP:0002322) | 1.79586845 |
| 160 | Incomplete penetrance (HP:0003829) | 1.78806067 |
| 161 | Abnormality of the lower motor neuron (HP:0002366) | 1.77828594 |
| 162 | Hypoplastic labia majora (HP:0000059) | 1.76823596 |
| 163 | Postaxial foot polydactyly (HP:0001830) | 1.76566406 |
| 164 | Abnormal ciliary motility (HP:0012262) | 1.75185985 |
| 165 | Annular pancreas (HP:0001734) | 1.74967633 |
| 166 | Thickened helices (HP:0000391) | 1.74626013 |
| 167 | Narrow nasal bridge (HP:0000446) | 1.73938282 |
| 168 | Abnormal EKG (HP:0003115) | 1.73810232 |
| 169 | Macroglossia (HP:0000158) | 1.73505001 |
| 170 | Amyotrophic lateral sclerosis (HP:0007354) | 1.72781524 |
| 171 | Ventricular fibrillation (HP:0001663) | 1.72703903 |
| 172 | Humeroradial synostosis (HP:0003041) | 1.72417394 |
| 173 | Synostosis involving the elbow (HP:0003938) | 1.72417394 |
| 174 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.71569718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 9.43114674 |
| 2 | NTRK3 | 4.92478632 |
| 3 | EPHA4 | 4.47011722 |
| 4 | MAP3K9 | 3.48768797 |
| 5 | ACVR1B | 3.23303551 |
| 6 | BMPR1B | 3.14614812 |
| 7 | MARK1 | 3.06101265 |
| 8 | MAP3K4 | 2.92713573 |
| 9 | ADRBK2 | 2.83067161 |
| 10 | MAP2K7 | 2.62701627 |
| 11 | NTRK2 | 2.62701618 |
| 12 | TNIK | 2.48741720 |
| 13 | MINK1 | 2.46039286 |
| 14 | INSRR | 2.45608900 |
| 15 | CASK | 2.31623564 |
| 16 | NTRK1 | 2.23834900 |
| 17 | DAPK2 | 2.02849075 |
| 18 | PNCK | 1.92733833 |
| 19 | PAK6 | 1.90361280 |
| 20 | KSR2 | 1.90218704 |
| 21 | MKNK2 | 1.89793525 |
| 22 | GRK1 | 1.86064770 |
| 23 | ZAK | 1.82368389 |
| 24 | MAP2K4 | 1.75014434 |
| 25 | MAP3K12 | 1.74155910 |
| 26 | NUAK1 | 1.63313487 |
| 27 | FES | 1.59478985 |
| 28 | RIPK4 | 1.52184742 |
| 29 | CDK5 | 1.51617023 |
| 30 | CAMKK1 | 1.46095972 |
| 31 | KSR1 | 1.45463440 |
| 32 | MAPK13 | 1.44740103 |
| 33 | GRK5 | 1.44506150 |
| 34 | SIK2 | 1.42298402 |
| 35 | TAOK3 | 1.40362283 |
| 36 | PRKCG | 1.39887345 |
| 37 | PRKD3 | 1.39595122 |
| 38 | PLK2 | 1.38950777 |
| 39 | TLK1 | 1.30425767 |
| 40 | MAP3K2 | 1.26359231 |
| 41 | DAPK1 | 1.23253419 |
| 42 | PHKG1 | 1.22305441 |
| 43 | PHKG2 | 1.22305441 |
| 44 | WNK4 | 1.20612886 |
| 45 | STK38L | 1.16823926 |
| 46 | CAMK2A | 1.13840590 |
| 47 | ARAF | 1.12564762 |
| 48 | STK39 | 1.11417908 |
| 49 | TYRO3 | 1.08353273 |
| 50 | CAMKK2 | 1.08208264 |
| 51 | STK38 | 1.04616150 |
| 52 | CDK19 | 1.03423943 |
| 53 | PRPF4B | 1.03323676 |
| 54 | AKT3 | 1.02691348 |
| 55 | MUSK | 1.02604552 |
| 56 | MAP4K2 | 1.02376114 |
| 57 | TGFBR1 | 1.01196885 |
| 58 | MAP3K13 | 0.99553432 |
| 59 | UHMK1 | 0.96820294 |
| 60 | CAMK1 | 0.95103459 |
| 61 | CSNK1G2 | 0.92244465 |
| 62 | LATS2 | 0.88350827 |
| 63 | LATS1 | 0.87903171 |
| 64 | SGK494 | 0.85159930 |
| 65 | SGK223 | 0.85159930 |
| 66 | PRKCE | 0.85122873 |
| 67 | CDK18 | 0.83690037 |
| 68 | CDK14 | 0.83115569 |
| 69 | CDK15 | 0.82867345 |
| 70 | PIK3CA | 0.82245211 |
| 71 | SGK2 | 0.81102628 |
| 72 | CAMK2B | 0.80505072 |
| 73 | CAMK1D | 0.79589027 |
| 74 | TNK2 | 0.77121211 |
| 75 | BRSK2 | 0.74941101 |
| 76 | PAK3 | 0.74592552 |
| 77 | PRKCH | 0.74527963 |
| 78 | SGK1 | 0.74186022 |
| 79 | STK11 | 0.73986671 |
| 80 | STK3 | 0.73722707 |
| 81 | LMTK2 | 0.72257153 |
| 82 | RAF1 | 0.71358729 |
| 83 | CDK11A | 0.71291582 |
| 84 | MKNK1 | 0.70704465 |
| 85 | MARK2 | 0.69756190 |
| 86 | CAMK1G | 0.68197350 |
| 87 | DYRK1A | 0.67912697 |
| 88 | MAPK12 | 0.67080937 |
| 89 | TAOK1 | 0.63777027 |
| 90 | RET | 0.62252100 |
| 91 | BMPR2 | 0.61061844 |
| 92 | TEC | 0.60705481 |
| 93 | OXSR1 | 0.60566297 |
| 94 | NEK6 | 0.60217166 |
| 95 | SGK3 | 0.59968359 |
| 96 | PINK1 | 0.58668376 |
| 97 | ERBB4 | 0.58608599 |
| 98 | PIK3CG | 0.58227788 |
| 99 | MAPKAPK3 | 0.57427158 |
| 100 | WNK3 | 0.57011180 |
| 101 | TXK | 0.55062340 |
| 102 | PTK2B | 0.54898517 |
| 103 | NLK | 0.53950565 |
| 104 | ALK | 0.53231949 |
| 105 | ERBB2 | 0.53159106 |
| 106 | TRPM7 | 0.52750615 |
| 107 | CAMK2D | 0.52647958 |
| 108 | CAMK2G | 0.52411702 |
| 109 | FYN | 0.52070418 |
| 110 | FGR | 0.52045420 |
| 111 | MAP2K1 | 0.51986617 |
| 112 | RPS6KA3 | 0.51419637 |
| 113 | PRKAA2 | 0.50989364 |
| 114 | CHUK | 0.49310414 |
| 115 | PRKCZ | 0.49089270 |
| 116 | MAP3K6 | 0.48803148 |
| 117 | CHEK2 | 0.48281127 |
| 118 | MAP3K1 | 0.47579125 |
| 119 | NEK2 | 0.47034297 |
| 120 | MELK | 0.46165228 |
| 121 | GRK7 | 0.45566917 |
| 122 | IRAK1 | 0.44463932 |
| 123 | OBSCN | 0.44437661 |
| 124 | WEE1 | 0.44078349 |
| 125 | FGFR2 | 0.43423400 |
| 126 | FER | 0.43375322 |
| 127 | CSNK1D | 0.43305403 |
| 128 | PDK1 | 0.42932478 |
| 129 | PKN1 | 0.42638642 |
| 130 | PDPK1 | 0.42341598 |
| 131 | MAPKAPK5 | 0.42130323 |
| 132 | DYRK2 | 0.41290239 |
| 133 | MAPK10 | 0.41053711 |
| 134 | CAMK4 | 0.39670985 |
| 135 | PRKAA1 | 0.39236339 |
| 136 | PRKCB | 0.37671672 |
| 137 | ADRBK1 | 0.37310687 |
| 138 | PLK4 | 0.35210587 |
| 139 | CDC42BPA | 0.34901946 |
| 140 | CSNK1A1L | 0.34743765 |
| 141 | PRKACA | 0.34578130 |
| 142 | CDK3 | 0.34510011 |
| 143 | PRKCA | 0.34069606 |
| 144 | MAP3K7 | 0.33612834 |
| 145 | SCYL2 | 0.33225651 |
| 146 | WNK1 | 0.32348029 |
| 147 | TAF1 | 0.31732038 |
| 148 | CSNK1G1 | 0.31495051 |
| 149 | PRKG1 | 0.31337992 |
| 150 | CSNK1A1 | 0.31244982 |
| 151 | PRKCQ | 0.30575148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.98712862 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.16562027 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 3.03363675 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.76378654 |
| 5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.66006115 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.64427899 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.63686721 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.61346259 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.46697648 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.42221348 |
| 11 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.21789200 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.17229519 |
| 13 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.16683137 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.13107157 |
| 15 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.09745026 |
| 16 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.07873838 |
| 17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.98285587 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.92971502 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.92946382 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.91566873 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.86045042 |
| 22 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.80111438 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.78901595 |
| 24 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.75000110 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.70579220 |
| 26 | ABC transporters_Homo sapiens_hsa02010 | 1.69227543 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.65958482 |
| 28 | Homologous recombination_Homo sapiens_hsa03440 | 1.63379325 |
| 29 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.59884820 |
| 30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.58643249 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.54765570 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.53129552 |
| 33 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.52786289 |
| 34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.47820246 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.42221265 |
| 36 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.37673615 |
| 37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37150246 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.34748571 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.34709655 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 1.34303875 |
| 41 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.33894109 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.33654346 |
| 43 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31453806 |
| 44 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.30651481 |
| 45 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29450798 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.26680919 |
| 47 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.24766897 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 1.24489665 |
| 49 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.22056606 |
| 50 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.20758089 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.15206999 |
| 52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.08281059 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06932701 |
| 54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06779556 |
| 55 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05427964 |
| 56 | Axon guidance_Homo sapiens_hsa04360 | 1.05204039 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 1.02122083 |
| 58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.00663237 |
| 59 | Retinol metabolism_Homo sapiens_hsa00830 | 0.99943200 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.99254452 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.95858272 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.94703829 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.94316984 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93743569 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.93584278 |
| 66 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90728679 |
| 67 | Glioma_Homo sapiens_hsa05214 | 0.90602991 |
| 68 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.90397420 |
| 69 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.88200683 |
| 70 | Lysine degradation_Homo sapiens_hsa00310 | 0.87125895 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.87086948 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83292581 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83051173 |
| 74 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81940703 |
| 75 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.80176786 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.79802124 |
| 77 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.77988336 |
| 78 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77854632 |
| 79 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77360044 |
| 80 | Phototransduction_Homo sapiens_hsa04744 | 0.75697979 |
| 81 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75063612 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72997211 |
| 83 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.72827167 |
| 84 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.68540642 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.68413520 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67883991 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66956013 |
| 88 | Basal transcription factors_Homo sapiens_hsa03022 | 0.66846062 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65919606 |
| 90 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.65847856 |
| 91 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.65281953 |
| 92 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.63102463 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62837333 |
| 94 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61845191 |
| 95 | Bile secretion_Homo sapiens_hsa04976 | 0.61639776 |
| 96 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.60540872 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.57715551 |
| 98 | Alcoholism_Homo sapiens_hsa05034 | 0.56680360 |
| 99 | RNA polymerase_Homo sapiens_hsa03020 | 0.56375141 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.54749162 |
| 101 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51937586 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51438101 |
| 103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50828882 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50590829 |
| 105 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49374481 |
| 106 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49263070 |
| 107 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48431318 |
| 108 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.48183134 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.47333029 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46563508 |
| 111 | Prion diseases_Homo sapiens_hsa05020 | 0.46034245 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45757973 |
| 113 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45241133 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.45183609 |
| 115 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43394220 |
| 116 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42714890 |
| 117 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42554600 |
| 118 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.42353029 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42185070 |
| 120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42039048 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40279393 |
| 122 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.40145116 |
| 123 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39550321 |
| 124 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.39135225 |
| 125 | Asthma_Homo sapiens_hsa05310 | 0.36989234 |
| 126 | Peroxisome_Homo sapiens_hsa04146 | 0.35904923 |
| 127 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35218013 |
| 128 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.35122200 |
| 129 | Melanoma_Homo sapiens_hsa05218 | 0.35082734 |
| 130 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.34763676 |
| 131 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33778601 |
| 132 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33619345 |
| 133 | Endocytosis_Homo sapiens_hsa04144 | 0.33072902 |
| 134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32815770 |
| 135 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31412630 |
| 136 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.30638561 |
| 137 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30154969 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.28853434 |
| 139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28635701 |
| 140 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.28452325 |
| 141 | Parkinsons disease_Homo sapiens_hsa05012 | 0.27058580 |
| 142 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.26088073 |
| 143 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26080340 |
| 144 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25770695 |
| 145 | Endometrial cancer_Homo sapiens_hsa05213 | 0.25204171 |
| 146 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.24817057 |

